![]() | |
Clinical data | |
---|---|
Other names | ECYPLA |
Legal status | |
Legal status |
|
Identifiers | |
| |
Chemical and physical data | |
Formula | C21H25N3O |
Molar mass | 335.451 g·mol−1 |
3D model (JSmol) | |
| |
|
ECPLA (N-ethyl-N-cyclopropyllysergamide) is an analog of lysergic acid diethylamide (LSD) developed by Synex Synthetics. In studies in mice, it was found to have approximately 40% the potency of LSD.[2][3]